Willow Biosciences is the result of a three-way merger between University of Calgary spinout Epimeron, BioCan Technologies and CSE-listed Makena Resources.

Epimeron, a Canada-based biotechnology spinout of University of Calgary, and cannabis producer BioCan Technologies have completed their reverse merger with exploration company Makena Resources to form Willow Biosciences. The new business listed on the Canadian Securities Exchange on Monday after completing a private placement of $29m, with cannabis-focused private equity firm Tuatara Capital supplying $21m.…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.